Gastroenterology 91��ĸ��Ƶ

Gastroenterology

Gastroenterology 91��ĸ��Ƶ

GastroIntestinal and Liver Disease 91��ĸ��Ƶ Group (GILDR)

The GILDR Group is a dynamic team of experienced 91��ĸ��Ƶ Nurses and 91��ĸ��Ƶ Assistants dedicated to advancing clinical trials and research studies. Our focus is on improving the quality of life for patients affected by gastrointestinal and liver diseases.

More about GILDR

PI-initiated Studies

Here are the current and upcoming studies initiated by our principal investigators (PI).

PI-initiated Studies

Protocol/PI	Disease	Study Length	High level Criteria	Coordinator	Status
Wind-PSC-01 Dr. Montano-Loza	Observational Primary Sclerosing Cholangitis	5 years	Incl: 18-75 yrs. of age, Confirmed clinical diagnosis of large duct PSC Excl: Clinically significant acute or chronic liver disease of an etiology other than PSC. Small-Duct PSC. IgG4-related sclerosing cholangitis. Prior liver transplantation MELD 3.0 Score >15	Rebecca Miller Rebecca.gildr@ualberta.ca Phone: 780-492-8291	Not open to recruitment
Ozmosis OZUHN-033 Dr. Montano-Loza	Open Label Hepatitis	72 weeks	Incl: 18-80 yrs. > 6 months (both type 1 and type 2) Exc: Primary Liver Disease other than AIH Advance Liver Disease. Biologic treatment exclusions to refer to coordinator Use in the prior month corticosteroids at doses exceeding the equivalent of prednisone 15 mg daily. Alcohol Drug Abuse. Infection History requiring treatment within 30–60 days of Day 0 (treatment and infection dependent.	Rebecca Miller Rebecca.gildr@ualberta.ca Phone: 780-492-8291	Not open to recruitment

CEGIIR

The Centre of Excellence for Gastrointestinal Inflammation and Immunity 91��ĸ��Ƶ (CEGIIR) brings together internationally recognized specialists in basic and clinical sciences and their research teams. They are actively involved in studying microbiome, genetic abnormalities and environmental factors associated with IBD.

CEGIIR is a multidisciplinary research centre devoted to understanding the genetic and environmental causes of inflammatory diseases, such as IBD. It is comprised of world-class researchers and clinician-researchers, trainees, and visiting researchers.